In November 2022, Australia's healthcare regulatory agency, the Therapeutic Products Administration (TGA) described that there was a world scarcity on the diabetic issues medication Ozempic. According to the TGA, the increase in need was caused by a rise in off-label prescription in the drug for fat reduction applications.[316] In December 2022, wi